NasdaqCM - Delayed Quote USD
Cardiol Therapeutics Inc. (CRDL)
1.1500
+0.0700
+(6.48%)
At close: April 29 at 4:00:00 PM EDT
1.1500
0.00
(0.00%)
After hours: April 29 at 4:05:05 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 3.31M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| Chao (Jennifer M) Director of Issuer | -- | Direct | -- | Apr 8, 2025 |
| Torreamione (Guilermo) Senior Officer of Issuer | Acquisition or disposition in the public market at price 1.26 per share. | Direct | 21,722 | Dec 26, 2024 |
| Hamer (Andrew Warwick M.D.) Senior Officer of Issuer | Acquisition or disposition in the public market at price 1.31 per share. | Direct | 24,721 | Dec 19, 2024 |
| Torreamione (Guilermo) Senior Officer of Issuer | Acquisition or disposition in the public market at price 1.45 per share. | Direct | 1,332 | Dec 18, 2024 |
| Lim (Bernard) Senior Officer of Issuer | Acquisition or disposition in the public market at price 1.36 per share. | Direct | 13,630 | Dec 17, 2024 |
| Pekos (Peter) Director of Issuer | Acquisition or disposition in the public market at price 1.29 per share. | Indirect | 49,987 | Dec 17, 2024 |
| Torreamione (Guilermo) Senior Officer of Issuer | Acquisition or disposition in the public market at price 1.31 per share. | Direct | 26,003 | Dec 17, 2024 |
| Elsley (David) Director of Issuer | Acquisition or disposition in the public market at price 1.32 per share. | Direct | 52,720 | Dec 16, 2024 |
| Torreamione (Guilermo) Senior Officer of Issuer | Acquisition or disposition in the public market at price 1.34 per share. | Direct | 999 | Dec 16, 2024 |
| Waddick (Christopher James) Director of Issuer | Acquisition or disposition in the public market at price 1.35 per share. | Direct | 34,887 | Dec 16, 2024 |
| Hamer (Andrew Warwick M.D.) Senior Officer of Issuer | -- | Direct | -- | Oct 25, 2024 |
| Chao (Jennifer M) Director of Issuer | -- | Direct | -- | Sep 6, 2024 |
| Hamer (Andrew Warwick M.D.) Senior Officer of Issuer | -- | Direct | -- | Sep 6, 2024 |
| Loxam (Teri) Director of Issuer | -- | Direct | -- | Sep 6, 2024 |
| Willner (Michael Jay) Director of Issuer | -- | Direct | -- | Sep 6, 2024 |
| Torreamione (Guilermo) Senior Officer of Issuer | -- | Direct | -- | Jul 3, 2024 |
| Elsley (David) Director of Issuer | Acquisition or disposition in the public market at price 2.03 per share. | Direct | 101,450 | Jun 24, 2024 |
Related Tickers
JUSHF Jushi Holdings Inc.
0.3460
+4.98%
TSNDF TerrAscend Corp.
0.3680
+15.00%
KNSA Kiniksa Pharmaceuticals International, plc
25.88
+20.54%
SHPH Shuttle Pharmaceuticals Holdings, Inc.
0.2930
-0.07%
AVCNF Avicanna Inc.
0.1800
0.00%
LOVFF Cannara Biotech Inc.
1.0200
-2.86%
SSLCF SIMPLY SOLVENTLESS CONCENTRATES
0.4300
0.00%
PCLO.V PharmaCielo Ltd.
0.0700
0.00%
IMCC IM Cannabis Corp.
1.5000
+0.67%
AAWH Ascend Wellness Holdings, Inc.
0.4100
+5.13%